查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722945

2025 年至 2033 年合成生物學市場規模、佔有率、趨勢及預測（依產品、技術、應用及地區）

Synthetic Biology Market Size, Share, Trends and Forecast by Product, Technology, Application, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球合成生物學市場規模價值 185 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 667 億美元，2025 年至 2033 年的複合年成長率為 15.3%。北美目前佔據市場主導地位，到 2024 年市佔率將超過 41.8%。北美的主導地位可以歸因於強大的生物技術基礎設施、對研究業務的不斷增加的投資以及政府的支持措施。

合成生物學市場分析：

主要市場促進因素：受基因編輯技術不斷進步的推動，全球合成生物學市場正經歷強勁成長。

主要市場趨勢：學術界、工業界和政府之間的合作努力正在增強創新和發展能力。

地理趨勢：由於對生物技術的投資不斷增加，北美佔據市場主導地位。然而，由於亞太地區研究活動和政府措施的不斷增加，亞太地區正在成為一個快速成長的市場。

競爭格局：主要參與者正在投資研究業務以推動創新並應對複雜的生物挑戰。合成生物學產業的主要市場參與者包括 GenScript Biotech Corporation、Amyris Inc.、Ginkgo Bioworks、Mammoth Biosciences、Novozymes、Merck KGaA 等。

挑戰與機會：挑戰包括與基因改造產品相關的道德和安全問題。儘管如此，市場可望開發符合法規、符合道德規範的創新機會來克服這些挑戰。

合成生物學市場趨勢/促進因素：

基因編輯技術的進步

目前，CRISPR-Cas9 等各種技術能夠透過精確且有效率地操縱遺傳物質來改善生物學研究領域，從而增強合成生物學市場的需求。研究人員正在以極高的精度設計、編輯和改造 DNA 序列，從而促進根據特定功能客製化的複雜合成生物的誕生。這項創新為新領域的發展開闢了新途徑，例如透過基因療法治療疾病以及創造能夠生產酶和生物燃料等有價值化合物的生物工程生物，從而有助於市場擴張。此外，世界衛生組織（WHO）發布了人類基因組編輯全球治理的開創性建議，強調安全性、有效性和道德性。

對永續解決方案的需求

各行各業對永續和環保解決方案的需求不斷成長，推動了合成生物學市場的發展。合成生物學為各行各業提供了各種新途徑來滿足其減少營運對環境影響的需求。與此相符的是，從可再生資源中提取的生物塑膠的生產以及符合全球永續發展要求的減少碳排放的生物燃料的開發正在促進市場成長。除此之外，合成生物學能夠創造微生物用於生物修復，這是一種去除污染物或幫助清潔環境並解決各種緊急生態問題的方法。此外，合成生物學正在徹底改變美容產業的永續發展努力。 Vogue Business 估計，每年有 20% 至 40% 的美容產品被廢棄，該行業每年產生 1200 億個難以回收的包裝。此外，十分之八的化妝品成分都來自不永續的來源。為了應對這些挑戰，合成生物學會修改微生物 DNA 以創造永續材料。合成生物學市場價格因創新和多樣化應用而呈現快速成長。

協作生態系統與投資

學術界、工業界和政府實體之間的協作協同作用為合成生物學領域的研究活動創造了有利的環境。合作促進了知識、資產和觀點的交流，從而加快了發明的速度。管理當局經常提供補助金和資金來協助研究工作，而成熟企業和新創公司則共同努力，匯集資源用於促進市場成長的開創性計畫。此外，創投對生物技術新創企業的投資激增，為該領域注入了重要的資本，促進了新興創意成長為有形產品和合成生物學市場應用。這個協作生態系統維持研究、創新和商業化的循環，推動全球合成生物學市場向前發展。

此外，合成生物學市場的未來有望帶來無與倫比的創新、永續性解決方案和廣闊的成長潛力。 Algal Bio 等公司利用多種菌株來創新解決方案，而 Basecamp Research 等新創公司則採用機器學習 (ML) 來破解自然界的合成蛋白質工程設計原理。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球合成生物學市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 寡核苷酸/寡核苷酸池和合成DNA
  • 酵素
  • 克隆技術試劑盒
  • 異種核酸
  • 底盤有機體

第7章：市場區隔：依技術

  • NGS技術
  • PCR技術
  • 基因組編輯技術
  • 生物加工技術
  • 其他

第 8 章：市場區隔：按應用

  • 衛生保健
    • 關鍵部分
      • 臨床
      • 非臨床/研究
  • 非醫療保健
    • 關鍵部分
      • 生物技術作物
      • 特種化學品
      • 生物燃料
      • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Amyris Inc.
    • Codexis Inc.
    • Danaher Corporation
    • Eurofins Scientific
    • GenScript Biotech Corporation
    • Illumina Inc.
    • Merck KGaA
    • New England Biolabs
    • Synthego Corporation
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience
    • Viridos Inc.
Product Code: SR112025A5534

The global synthetic biology market size was valued at USD 18.5 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 66.7 Billion by 2033, exhibiting a CAGR of 15.3% from 2025-2033. North America currently dominates the market, holding a market share of over 41.8% in 2024. The dominance of North America can be attributed to robust biotechnology infrastructure, increasing investments in research operations, and supportive government initiatives.

Synthetic Biology Market Analysis:

Major Market Drivers: The global synthetic biology market is experiencing robust growth, driven by increasing improvements in gene editing technologies.

Key Market Trends: Collaborative efforts between academia, industry, and government are enhancing innovation and development capabilities.

Geographical Trends: North America dominates the market owing to the growing investments in biotechnology. However, Asia Pacific is emerging as a fast-growing market due to the increasing research activities and government initiatives in the region.

Competitive Landscape: Key players are investing in research operations to drive innovation and address complex biological challenges. Some of the major market players in the synthetic biology industry include GenScript Biotech Corporation, Amyris Inc., Ginkgo Bioworks, Mammoth Biosciences, Novozymes, Merck KGaA, among many others.

Challenges and Opportunities: Challenges include ethical and safety concerns related to genetically modified products. Nonetheless, opportunities for the market to develop regulatory-compliant, ethically considered innovations are projected to overcome these challenges.

Synthetic Biology Market Trends/Drivers:

Advancements in gene editing technologies

At present, various techniques like CRISPR-Cas9 are capable of improving the field of biology research by enabling precise and efficient manipulation of genetic material, strengthening the synthetic biology market demand. Researchers are designing, editing, and engineering DNA sequences with exceptional accuracy, facilitating the creation of intricate synthetic organisms customized according to specific functions. This innovation is opening new avenues for the development of novel aspects, like disease treatment through gene therapies and creation of bioengineered organisms capable of producing valuable compounds such as enzymes and biofuels, thus aiding in market expansion. Moreover, The World Health Organization (WHO) released groundbreaking recommendations for the global governance of human genome editing, emphasizing safety, efficacy, and ethics.

Demand for sustainable solutions

The rising demand for sustainable and environment-friendly solutions across various industries is propelling the synthetic biology market. Synthetic biology presents various new avenues for sectors to fulfill their demands to reduce the environmental impact of their operations. In line with this, the production of bioplastics extracted from renewable resources and the development of biofuels with reduced carbon emissions aligning with the global push towards sustainability are contributing to the market growth. Apart from this, synthetic biology is capable of creating microbes for bioremediation which is a method to detoxify contaminants or help clean up the environment and address various urgent ecological complications. Furthermore, synthetic biology is revolutionizing the sustainability efforts of the beauty sector. Vogue Business estimates that 20-40% of beauty products become waste annually, and the industry generates 120 billion units of difficult-to-recycle packaging yearly. Moreover, eight out of ten cosmetic ingredients are unsustainably sourced. To address these challenges, synthetic biology modifies microorganism DNA to create sustainable materials. The synthetic biology market price reflects rapid growth due to innovation and diverse applications.

Collaborative ecosystem and investment

The collaborative synergy between academia, industry, and government entities fosters a conducive environment for research operations within the synthetic biology field. Collaborations facilitate the exchange of knowledge, assets, and perspectives, thus quickening the rate of invention. Governing authorities frequently provide grants and funds to assist research endeavors, while established businesses and startups work together to pool resources for ground-breaking ventures that promote market growth. In addition to this, the surge in venture capital investments in biotechnology startups injects vital capital into the field, nurturing the growth of nascent ideas into tangible products and synthetic biology market application. This collaborative ecosystem sustains a cycle of research, innovation, and commercialization, propelling the global synthetic biology market forward.

Additionally, the future of the synthetic biology market promises unparalleled innovation, sustainability solutions, and expansive growth potential. Companies, such as Algal Bio utilize a diverse array of strains to innovate novel solutions, while startups like Basecamp Research employ machine learning (ML) to decipher the design principles of nature for synthetic protein engineering.

Synthetic Biology Industry Segmentation:

Breakup by Product:

  • Oligonucleotide/Oligo Pools and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Xeno-nucleic Acids
  • Chassis Organism

Oligonucleotide/oligo pools and synthetic DNA dominates the market

The growing demand for synthetic biology products, specifically oligonucleotide/oligo pools and synthetic DNA, is mainly fueled by the exponential growth in fields such as personalized medicine, gene therapy, and molecular diagnostics that have amplified the need for precise and customizable genetic materials. Additionally, the rise of synthetic biology startups and the democratization of gene editing technologies have made these products more accessible, empowering researchers across diverse disciplines to engage in innovative projects, thereby creating a favorable synthetic biology market outlook. For example, Synbio Technologies offers oligo pool synthesis for companies or clients who need to mass-produce short DNA strands, also known as oligonucleotides.

Breakup by Technology:

  • NGS Technology
  • PCR Technology
  • Genome Editing Technology
  • Bioprocessing Technology
  • Others

Next-generation sequencing (NGS) technology has become instrumental in deciphering complex biological information, facilitating the analysis of vast genetic data sets, and accelerating the discovery of novel genetic components, which in turn, is presenting lucrative market opportunities. Moreover, polymerase chain reaction (PCR) technology remains a cornerstone for DNA amplification, crucial in generating sufficient genetic material for various applications, from research to diagnostics. Besides this, genome editing technologies, particularly CRISPR-Cas9, hold immense promise for precision genetic modifications, driving advancements in gene therapies and customized genetic engineering. Bioprocessing technologies form a critical facet, enabling efficient large-scale production of bioengineered compounds, ranging from pharmaceuticals to biofuels. Companies are also investing and focusing on these aspects to create novel technologies. For example, Bayer and Mammoth Biosciences collaborated to develop a novel gene editing technology to unlock the full potential of CRISPR systems.

Additionally, the synthetic biology market statistics highlight a robust growth trajectory, driven by advancements in biotechnology and increasing investment in research and development.

Breakup by Application:

  • Healthcare
  • Clinical
  • Non-Clinical/Research
  • Non-Healthcare
  • Biotech Crops
  • Specialty Chemicals
  • Bio-Fuels
  • Others

The bolstering growth of the healthcare sector, wherein synthetic biology is used in the development of personalized medicines, gene therapies, and diagnostics, is contributing to the synthetic biology market growth. In addition, the numerous non-clinical or research applications of synthetic biology encompassing drug discovery, functional genomics, and biomolecule production, are fueling scientific exploration and market growth. Beyond healthcare, synthetic biology's expanding usage in biotech crops engineered for improved yield and resistance to pests is positively influencing the market. Furthermore, the increasing product adoption across the specialty chemicals industry, wherein bioengineered pathways create sustainable routes to produce high-value compounds is impelling the market growth. Apart from this, the growing use of synthetic biology in the biofuel sector to optimize microorganisms for efficient biofuel production is strengthening the market growth. Key market players are focusing on collaborating with each other to develop various novel technologies in synthetic biology. For instance, scientists led by Gerard Wright at McMaster University developed a synthetic biology platform for novel glycopeptide antibiotics (GPA) discovery. They engineered Streptomyces coelicolor as a chassis for GPA biosynthesis, overcoming challenges in cloning large biosynthetic gene clusters (BGCs) using an optimized transformation-associated recombination (TAR) system. The platform enabled the synthesis of corbomycin and the discovery of novel GPAs, expanding antibiotic candidates' repertoire.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest synthetic biology market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The presence of a well-established research and innovation ecosystem in North America, characterized by leading academic institutions, cutting-edge biotechnology companies, and significant government investments, provides a fertile ground for advancements in synthetic biology. Moreover, the region's emphasis on R&D and technological innovation fosters collaborations that span academia and industry, driving the development of novel applications across sectors including healthcare, agriculture, and energy. In addition to this, the increasing focus on sustainable solutions and the demand for eco-friendly products align with synthetic biology's potential to offer greener alternatives. This, coupled with favorable regulatory frameworks that encourage biotechnology R&D, creates an environment conducive to the expansion of the North American synthetic biology market. In December 2022, the Investment Strategy by the Office of Strategic Capital (OSC) identifies synthetic biology as a priority technology area for private sector investment, aiming to attract capital and foster innovation in this field for national security purposes. The synthetic biology market overview reveals its rapid expansion, driven by innovation, research investment, and diverse applications.

Competitive Landscape:

The global synthetic biology market features a dynamic competitive landscape shaped by a blend of established players and innovative startups. Leading companies, with their significant financial resources and expansive research capabilities, dominate the market by offering a diverse range of synthetic biology products and services and highlighting how big is the synthetic biology market? These companies actively engage in collaborations, strategic partnerships, and mergers to enhance their offerings and expand their market reach. Furthermore, a surge in venture capital investments has catalyzed the emergence of agile startups, injecting fresh ideas and disruptive technologies into the field. The competitive arena is characterized by a focus on innovation, technology integration, and the ability to address diverse market segments, accentuating the evolutionary nature of the global synthetic biology market. On of the key players, Eurofins Genomics Blue Heron, introduced its IVT mRNA Synthesis Service, using cutting-edge technology for rapid and efficient mRNA transcript production. Tailored for various fields including molecular biology and gene therapy, it offers customizable synthesis with quick turnaround times and expert support, benefiting synthetic biology research and applications. According to synthetic biology market recent news, Aanika Biosciences is revolutionizing synthetic biology adoption across industries like food and agriculture through insurance. Their subsidiary, Aanika Insurance Services (AIS), offers cost-effective coverage, encouraging biologic use while ensuring risk mitigation and frequent sampling. Partnering with Western Growers Insurance Services, Aanika aims to expand its reach to farmers, distributors, and retailers.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Agilent Technologies Inc.
  • Amyris Inc.
  • Codexis Inc.
  • Danaher Corporation
  • Eurofins Scientific
  • GenScript Biotech Corporation
  • Illumina Inc.
  • Merck KGaA
  • New England Biolabs
  • Synthego Corporation
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience
  • Viridos Inc.

Key Questions Answered in This Report

  • 1.What is synthetic biology?
  • 2.How big is the synthetic biology market?
  • 3.What is the expected growth rate of the global synthetic biology market during 2025-2033?
  • 4.What are the key factors driving the global synthetic biology market?
  • 5.What is the leading segment of the global synthetic biology market based on product?
  • 6.What is the leading segment of the global synthetic biology market based on technology?
  • 7.What is the leading segment of the global synthetic biology market based on application?
  • 8.What are the key regions in the global synthetic biology market?
  • 9.Who are the key players/companies in the global synthetic biology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Synthetic Biology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oligonucleotide/Oligo Pools and Synthetic DNA
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Enzymes
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cloning Technologies Kits
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Xeno-nucleic Acids
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Chassis Organism
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 NGS Technology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 PCR Technology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Genome Editing Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Bioprocessing Technology
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Clinical
      • 8.1.2.2 Non-Clinical/Research
    • 8.1.3 Market Forecast
  • 8.2 Non-Healthcare
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Biotech Crops
      • 8.2.2.2 Specialty Chemicals
      • 8.2.2.3 Bio-Fuels
      • 8.2.2.4 Others
    • 8.2.3 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amyris Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Codexis Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Eurofins Scientific
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GenScript Biotech Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Illumina Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 New England Biolabs
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Synthego Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Twist Bioscience
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Viridos Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio

List of Figures

  • Figure 1: Global: Synthetic Biology Market: Major Drivers and Challenges
  • Figure 2: Global: Synthetic Biology Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Synthetic Biology Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Synthetic Biology Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Synthetic Biology Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Synthetic Biology Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Synthetic Biology Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Synthetic Biology (Oligonucleotide/Oligo Pools and Synthetic DNA) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Synthetic Biology (Oligonucleotide/Oligo Pools and Synthetic DNA) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Synthetic Biology (Enzymes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Synthetic Biology (Enzymes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Synthetic Biology (Cloning Technologies Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Synthetic Biology (Cloning Technologies Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Synthetic Biology (Xeno-nucleic Acids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Synthetic Biology (Xeno-nucleic Acids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Synthetic Biology (Chassis Organism) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Synthetic Biology (Chassis Organism) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Synthetic Biology (NGS Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Synthetic Biology (NGS Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Synthetic Biology (PCR Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Synthetic Biology (PCR Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Synthetic Biology (Genome Editing Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Synthetic Biology (Genome Editing Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Synthetic Biology (Bioprocessing Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Synthetic Biology (Bioprocessing Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Synthetic Biology (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Synthetic Biology (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Synthetic Biology (Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Synthetic Biology (Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Synthetic Biology (Non-Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Synthetic Biology (Non-Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Synthetic Biology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Synthetic Biology Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Synthetic Biology Industry: SWOT Analysis
  • Figure 82: Global: Synthetic Biology Industry: Value Chain Analysis
  • Figure 83: Global: Synthetic Biology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Synthetic Biology Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Synthetic Biology Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Synthetic Biology Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Synthetic Biology Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Synthetic Biology Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Synthetic Biology Market: Competitive Structure
  • Table 7: Global: Synthetic Biology Market: Key Players